P&G ALEVE DURATION-OF-ACTION DATA "NOT INCONSISTENT" WITH AD CLAIMS
This article was originally published in The Tan Sheet
Executive Summary
P&G ALEVE DURATION-OF-ACTION DATA "NOT INCONSISTENT" WITH AD CLAIMS, the National Advertising Division of the Council for Better Business Bureaus determined in a Nov. 10 case report. Procter & Gamble's clinical evidence supports claims that "Aleve's analgesic effect will last longer than Tylenol and has a tendency to last longer than ibuprofen," NAD said.